Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
SIBN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.70 - $19.16
Previous CloseN/A
Volume50.81K
Average Volume (3M)467.20K
Market Cap
$596.04M
Enterprise Value$476.20M
Total Cash (Recent Filing)$17.60M
Total Debt (Recent Filing)$15.15M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
May 12, 2025EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding42,453,117
10 Day Avg. Volume358,939
30 Day Avg. Volume467,199
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.72
Price to Cash Flow (P/CF)132.10
P/FCF Ratio132.10
Enterprise Value/Market Cap0.80
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.60
Enterprise Value/Ebitda-20.62
Forecast
1Y Price Target
$24.57Price Target Upside75.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
SI-Bone News
PremiumCompany Announcements
SI-BONE’s Earnings Call Highlights Strong Growth Amid Challenges
PremiumCompany Announcements
SI-BONE, Inc. Reports Record Growth and Positive EBITDA---
Bulls Say, Bears Say
Bulls Say
FDA RecognitionSIBN has received FDA Breakthrough Device Designation for multiple products, indicating a strong pipeline of innovative solutions.
Product Launch SuccessThe launch of the Granite 9.5 product and the TNT product exceeded expectations, showcasing strong market engagement.
Revenue And Profitability OutlookSIBN expects continued revenue growth and operating leverage, with adjusted EBITDA profitability anticipated in the future.
Bears Say
Market ExpectationsSIBN's territory productivity has nearly doubled over the last three years, and further expansion of the direct sales force is expected to enhance market penetration.
Revenue Projection RisksThere could be upside to SIBN's revenue guidance which likely drops through to profitability.
---
Ownership Overview
4.87% Insiders
28.87% Mutual Funds
13.88% Other Institutional Investors
40.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SIBN FAQ
What was SI-Bone Inc’s price range in the past 12 months?
SI-Bone Inc lowest stock price was $11.70 and its highest was $19.16 in the past 12 months.
What is SI-Bone Inc’s market cap?
SI-Bone Inc’s market cap is $596.04M.
When is SI-Bone Inc’s upcoming earnings report date?
SI-Bone Inc’s upcoming earnings report date is May 12, 2025 which is in 41 days.
How were SI-Bone Inc’s earnings last quarter?
SI-Bone Inc released its earnings results on Feb 24, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.145 by $0.035.
Is SI-Bone Inc overvalued?
According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued.
Does SI-Bone Inc pay dividends?
SI-Bone Inc does not currently pay dividends.
What is SI-Bone Inc’s EPS estimate?
SI-Bone Inc’s EPS estimate is -0.23.
How many shares outstanding does SI-Bone Inc have?
SI-Bone Inc has 42,453,117 shares outstanding.
What happened to SI-Bone Inc’s price movement after its last earnings report?
SI-Bone Inc reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.145. Following the earnings report the stock price went up 5.552%.
Which hedge fund is a major shareholder of SI-Bone Inc?
Currently, no hedge funds are holding shares in SIBN
---
SI-Bone Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.57 (75.00% Upside)
$24.57 (75.00% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 233.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.23%
12-Months-Change
Fundamentals
Return on Equity
-18.38%
Trailing 12-Months
Asset Growth
<0.01%
Trailing 12-Months
Company Description
SI-Bone Inc
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
---
SIBN Company Deck
---
SIBN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, successful product launches, and positive adjusted EBITDA, indicating robust business momentum. However, challenges such as the ongoing DOJ investigation and assumptions of ASP decline provide some areas of concern.Read More>---
SIBN Stock 12 Month Forecast
Average Price Target
$24.57
▲(75.00% Upside)
Technical Analysis
Best Analysts Covering SIBN
1 Year
1 Year Success Rate
11/33 ratings generated profit
1 Year Average Return
-3.63%
reiterated a buy rating last month
Copying David Saxon's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -3.63% per trade.
---